Vaccine News and Research

Latest Vaccine News and Research

New nurse-led techniques show promise in reducing children's needle fear

Tears, tantrums, and distress – when it comes to needles, many children struggle with anxiety. But with vaccinations becoming more regular, finding ways to help reduce needle-related fear and pain is high on the agenda.

12 Aug 2022

National follow-up study identifies risk factors for a prolonged COVID-19 recovery

In one of the largest follow-up studies to date, involving 25 pediatric hospitals, more than a quarter of children and adolescents hospitalized with coronavirus infection early in the pandemic still had health problems two to four months later, either persisting symptoms or activity impairment. The study, led by Boston Children's Hospital, is published August 12 in the journal Pediatrics.

12 Aug 2022

Democrats didn’t achieve all their goals, but inflation reduction act makes historic Medicare changes

The giant health care, climate, and tax bill expected to pass the House on Friday and be sent to the president for his signature won’t be as sweeping as the Democrats who wrote it had hoped, but it would help millions of Americans better afford their prescription drugs and health insurance.

12 Aug 2022

Big pharma went all in to kill drug pricing negotiations

For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits.

12 Aug 2022

How is artificial intelligence used in COVID-19 research?

A new study discussed the roles of artificial intelligence (AI) in combating the COVID-19 pandemic.

12 Aug 2022

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Now, a group of prominent scientists and physicians are urging the FDA to include in its guidance to vaccine developers a recommendation for T-cell assessment in COVID-19 vaccine clinical trials to more comprehensively measure immune response.

11 Aug 2022

Novel zoonotic Langya virus identified in China

Scientists discuss their discovery of the novel Langya henipavirus in eastern China.

11 Aug 2022

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.

11 Aug 2022

Large Canadian study suggests COVID-19 mRNA vaccines are safe to use in pregnancy

COVID-19 mRNA vaccines are safe to use in pregnancy and pregnant women experienced lower rates of health events post vaccination than similarly aged, non-pregnant vaccinated people, suggests a large Canadian study published in The Lancet Infectious Diseases journal.

11 Aug 2022

Assessment of replicon ribonucleic acid COVID-19 vaccine in nonhuman primates

Researchers explored the immunogenicity of a replicon ribonucleic acid (repRNA) COVID-19 vaccine, repRNA-CoV2S, in pigtail macaques.

11 Aug 2022

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

A new study identified the gut microbial and immune variables linked to heterogeneous messenger ribonucleic acid (mRNA) COVID-19 vaccine responses between individuals.

11 Aug 2022

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

Researchers described a novel protein subunit vaccine comprising the receptor-binding domain (RBD) of ancestral SARS-CoV-2 spike (S) protein, dimerized with an immunoglobulin (Ig)G1-fraction, crystallizable (Fc) domain.

11 Aug 2022

Nanoparticle-based lateral flow immunoassay for the detection of anti-SARS-CoV-2 neutralizing antibodies

In a recent Biomaterials study, researchers developed AIEgen-embedded polystyrene (PS) nanoparticles-based LFIA that can accurately detect anti-SARS-CoV-2 NAb in serum samples of vaccinated individuals.

11 Aug 2022

Can adults identify pain in babies’ cries?

In a recent Current Biology study, researchers detected that a baby’s cry expresses the pain that can be actually recognized through experience.

11 Aug 2022

Review of natural products with promising anti-SARS-CoV-2 potential

In a new study, researchers reviewed existing literature on naturally active products with therapeutic efficacy against SARS-CoV-2.

10 Aug 2022

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Researchers analyzed the characteristics of coronaviruses and novel CoV vaccine candidates.

10 Aug 2022

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Researchers conducted phase 3 evaluations of the immunogenicity of the two immunization timeframes of the CoronaVac COVID-19 vaccine among Chilean adults.

10 Aug 2022

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists. The warning comes following the results of a new study, published in The Lancet Regional Health - Europe, which found that over 55% of respiratory disease hospitalizations during the pandemic's peak were caused by non-SARS-CoV-2 infections.

10 Aug 2022

A broad sarbecovirus-neutralizing antibody cocktail

Researchers present a rational approach for identifying SARS-CoV-2 receptor-binding domain-targeted broad neutralizing antibody cocktails.

9 Aug 2022

Next-generation monoclonal antibody prevents malaria

Researchers investigate the pharmacokinetics and safety of L9LS, a monoclonal antibody to prevent malaria.

9 Aug 2022

Vaccine News and Research

Latest Vaccine News and Research

New nurse-led techniques show promise in reducing children's needle fear

National follow-up study identifies risk factors for a prolonged COVID-19 recovery

Democrats didn’t achieve all their goals, but inflation reduction act makes historic Medicare changes

Big pharma went all in to kill drug pricing negotiations

How is artificial intelligence used in COVID-19 research?

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Novel zoonotic Langya virus identified in China

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Large Canadian study suggests COVID-19 mRNA vaccines are safe to use in pregnancy

Assessment of replicon ribonucleic acid COVID-19 vaccine in nonhuman primates

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

Nanoparticle-based lateral flow immunoassay for the detection of anti-SARS-CoV-2 neutralizing antibodies

Can adults identify pain in babies’ cries?

Review of natural products with promising anti-SARS-CoV-2 potential

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

A broad sarbecovirus-neutralizing antibody cocktail

Next-generation monoclonal antibody prevents malaria

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in